These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 171510)

  • 1. Steroids and human breast cancer.
    McGuire WL; Chamness GC; Costlow ME; Richert NJ
    J Steroid Biochem; 1975 May; 6(5):723-7. PubMed ID: 171510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and progesterone receptor proteins in breast cancer.
    Edwards DP; Chamness GC; McGuire WL
    Biochim Biophys Acta; 1979 Dec; 560(4):457-86. PubMed ID: 391286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and breast carcinoma.
    Smithline F; Sherman L; Kolodny D
    N Engl J Med; 1975 Apr; 292(15):784-92. PubMed ID: 1089886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological detection of oestrogen receptor in human breast carcinomas.
    Walker RA; Cove DH; Howell A
    Lancet; 1980 Jan; 1(8161):171-3. PubMed ID: 6153438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible retention of the estrogen-binding capacity after endocrine ablation therapy in the rat and human breast cancer.
    Nomura Y; Abe Y; Yamagata J; Takenaka K
    Gan; 1976 Feb; 67(1):101-4. PubMed ID: 178562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estradiol binding to nuclear receptors in human breast cancer tissue (MCF-7 cell line) and in dimethylbenz(a)anthracene-induced mammary carcinoma.
    Geier A; Cocos M; Ginzburg R; Haimsohn M; Lunenfeld B
    J Clin Endocrinol Metab; 1979 Jul; 49(1):34-9. PubMed ID: 109464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine ablation for metastatic breast cancer: a reappraisal of hormone receptors.
    Moseley HS; Peetz ME; Keenan EJ; Awrich AE; Fletcher WS
    Am J Surg; 1980 Jul; 140(1):164-72. PubMed ID: 7396080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: Hormone receptors and breast cancer.
    Br Med J; 1976 Jul; 2(6027):67-8. PubMed ID: 179660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of nuclear estrogen receptors by charcoal adsorption: relationships of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Nishimura R; Kimura M; Tokunaga T; Akagi M
    Gan; 1982 Oct; 73(5):713-20. PubMed ID: 6187619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of progesterone in DNA synthesis of pregnancy-dependent mammary tumors in mice.
    Yanai R; Nagasawa H
    Int J Cancer; 1976 Sep; 18(3):317-21. PubMed ID: 986372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of estrogen receptors in human breast cancer.
    McGuire WL
    Cancer; 1975 Aug; 36(2):638-44. PubMed ID: 168960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of cytoplasmic and nuclear estrogen receptors. A histochemical study on human mammary cancer and rabbit uterus.
    Lee SH
    Cancer; 1989 Oct; 64(7):1461-6. PubMed ID: 2550122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and pharmacological effects of estrogens in breast cancer.
    Leclercq G; Heuson JC
    Biochim Biophys Acta; 1979 Dec; 560(4):427-55. PubMed ID: 391285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer of the breast. Endocrine and hormonal therapy.
    Kardinal CG; Donegan WL
    Major Probl Clin Surg; 1979; 5():361-404. PubMed ID: 379452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple hormone-receptor assay: a more accurate predictive tool for the treatment of advanced breast cancer?
    Barnes DM; Skinner LG; Ribeiro GG
    Br J Cancer; 1979 Dec; 40(6):862-5. PubMed ID: 230853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inter-site variation of oestrogen receptors in human breast cancers.
    Tilley WD; Keightley DD; Cant EL
    Br J Cancer; 1978 Oct; 38(4):544-6. PubMed ID: 728342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
    Lunenfeld B; Geier A
    Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.